Semaglutide is effective in type 2 diabetes and obesity with schizophrenia
K Noda, T Kato, N Nomura, M Sakai, S Kubota… - Diabetology …, 2022 - Springer
Background Prevention and treatment of type 2 diabetes and obesity are problematic for
individuals with schizophrenia partly because atypical antipsychotics and mental distress …
individuals with schizophrenia partly because atypical antipsychotics and mental distress …
Glucagon-Like Peptide-1 Receptor Agonist Cases Reported to United States Poison Centers, 2017–2022
Introduction Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are a class of
medications for management of diabetes and obesity. The objective of this study is to …
medications for management of diabetes and obesity. The objective of this study is to …
GLP-1 Receptor Agonist Exposures Are Increasingly Common and Generally Associated with Mild Symptoms: A Single Poison Center Experience
S Marshall, E Ryan, J Rivera, L Reynolds… - Journal of Medical …, 2024 - Springer
Introduction Glucagon-like peptide-1 receptor agonist use has increased over the last
decade for glycemic control in type 2 diabetes mellitus, cardiovascular risk reduction, and …
decade for glycemic control in type 2 diabetes mellitus, cardiovascular risk reduction, and …
Liraglutide overdose: A case report and an updated review
SB Nafisah, D Almatrafi… - Turkish journal of …, 2020 - journals.lww.com
Little is known about liraglutide overdose and in particular its association with hypoglycemia.
The aim of this study was to report on an accidental case of liraglutide overdose and to …
The aim of this study was to report on an accidental case of liraglutide overdose and to …
Accidental Once-Daily Use of Dulaglutide: A Case Report
HE Moore, V Zaya, CV Burns, HD Berlie - Clinical Diabetes, 2024 - diabetesjournals.org
There is a paucity of information regarding the misuse of weekly glucagon-like peptide 1
(GLP-1) receptor agonists taken once daily. This article presents a case report of a patient …
(GLP-1) receptor agonists taken once daily. This article presents a case report of a patient …
[HTML][HTML] Acute pancreatitis and euglycemic non-diabetic ketoacidosis caused by an intentional semaglutide overdose
A Acosta, A Fanco, H Rohan, Z Elfessi - JEM Reports, 2025 - Elsevier
Abstract Background Glucagon-like peptide-1 (GLP-1) receptor agonists, such as
semaglutide, have been approved for weight loss and have gained popularity for its efficacy …
semaglutide, have been approved for weight loss and have gained popularity for its efficacy …